• Log in
Greater Manchester Medicines Management Group - GMMMG logo
  • Home
    • Homepage
    • News Summary
    • Consultations
    • Tariff Watch
  • Joint Formulary
    • BNF Chapters
    • Formulary Requests
  • RAG/DNP
    • RAG/DNP List
    • Paediatric RAG/DNP List
    • RAG Submissions
  • Shared Care
    • Approved Shared Care Protocols
  • GMMMG Guidance
    • Clinical guidance and pathways
    • Medicines and devices recommendations
    • Information leaflets for primary care prescribers
    • High cost drugs
    • Prescribing policies
    • Operational policies
    • Primary care rebate schemes
  • Meetings
    • Membership and Terms of Reference
    • Decision Summaries
    • GMMMG Meetings
    • Clinical Reference Group
    • GMMMG Process Documents
    • Subgroup Meetings Archives
Home » Amber » Page 3

Amber

Olanzapine

Naltrexone

Status depends on local commissioning arrangements for substance misuse

Mycophenolate

To remain amber until repatriation occurs

Mycophenolate

Methylphenidate

Atomoxetine, dexamfetamine, guanfacine, lisdexamfetamine and methylphenidate for ADHD In Adults

Methotrexate (oral)

Shared care protocols available for

Mercaptopurine

Lithium

Lithium for patients over 18 years old including those aged 65 years and older

Lisdexamfetamine

Atomoxetine, dexamfetamine, guanfacine, lisdexamfetamine and methylphenidate for ADHD In Adults

Lithium

Posts navigation

Older posts
Newer posts

Follow GMMMG on Twitter

  • Terms and Conditions
  • Contact
  • About us
  • RSS Feed